Cargando…

Understanding the crisis in harm reduction funding in Central and Eastern Europe

BACKGROUND: The harm reduction (HR) approach to injecting drug use was rapidly adopted in Central Europe following the fall of the Iron Curtain. The associated social and economic transformation had significant consequences for drug policies in the region. A large number of emerging services have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Miovský, Michal, Miklíková, Silvia, Mravčík, Viktor, Grund, Jean-Paul, Černíková, Tereza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579931/
https://www.ncbi.nlm.nih.gov/pubmed/33092597
http://dx.doi.org/10.1186/s12954-020-00428-6
_version_ 1783598694136807424
author Miovský, Michal
Miklíková, Silvia
Mravčík, Viktor
Grund, Jean-Paul
Černíková, Tereza
author_facet Miovský, Michal
Miklíková, Silvia
Mravčík, Viktor
Grund, Jean-Paul
Černíková, Tereza
author_sort Miovský, Michal
collection PubMed
description BACKGROUND: The harm reduction (HR) approach to injecting drug use was rapidly adopted in Central Europe following the fall of the Iron Curtain. The associated social and economic transformation had significant consequences for drug policies in the region. A large number of emerging services have been dependent on funding from a wide range of national and/or local funding programmes, which continue to be unstable, and closely associated with political decisions and insufficient institution building. A sharp distinction is made between health and social services, often without regard to client input. The main objective of the paper is to identify the causes of the funding problems currently faced by HR services in the context of their history of institution building which represents a major threat to the future of HR services in the region. METHODS: Qualitative content analysis of documents was conducted in the development of two case studies of the Czech and Slovak Republics. The body of documentation under study comprised policy documents, including National Drug Strategies, Action Plans, ministerial documents, and official budgets and financial schedules, as well as documents from the grey literature and expert opinions. RESULTS: The insufficient investments in finalising the process of the institution building of HR services have resulted in a direct threat to their sustainability. An unbalanced inclination to the institutionalisation of HR within the domain of social services has led to a misperception of their integrity, as well as to their funding and long-term sustainability being endangered. In addition, this tendency has had a negative impact on the process of the institutionalisation of HR within the system of healthcare. CONCLUSION: The case study revealed a lack of systemic grounding of HR services as interdisciplinary health-social services. The aftermath of the financial crisis in 2008 fully revealed the limitations of the funding system established ad hoc in the 1990s, which remains present until today, together with all its weak points. The entire situation is responsible for the dangerous erosion of the interpretation of the concept of harm reduction, which is supported by various stereotypes and false, or ideological, interpretations of the concept.
format Online
Article
Text
id pubmed-7579931
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75799312020-10-22 Understanding the crisis in harm reduction funding in Central and Eastern Europe Miovský, Michal Miklíková, Silvia Mravčík, Viktor Grund, Jean-Paul Černíková, Tereza Harm Reduct J Research BACKGROUND: The harm reduction (HR) approach to injecting drug use was rapidly adopted in Central Europe following the fall of the Iron Curtain. The associated social and economic transformation had significant consequences for drug policies in the region. A large number of emerging services have been dependent on funding from a wide range of national and/or local funding programmes, which continue to be unstable, and closely associated with political decisions and insufficient institution building. A sharp distinction is made between health and social services, often without regard to client input. The main objective of the paper is to identify the causes of the funding problems currently faced by HR services in the context of their history of institution building which represents a major threat to the future of HR services in the region. METHODS: Qualitative content analysis of documents was conducted in the development of two case studies of the Czech and Slovak Republics. The body of documentation under study comprised policy documents, including National Drug Strategies, Action Plans, ministerial documents, and official budgets and financial schedules, as well as documents from the grey literature and expert opinions. RESULTS: The insufficient investments in finalising the process of the institution building of HR services have resulted in a direct threat to their sustainability. An unbalanced inclination to the institutionalisation of HR within the domain of social services has led to a misperception of their integrity, as well as to their funding and long-term sustainability being endangered. In addition, this tendency has had a negative impact on the process of the institutionalisation of HR within the system of healthcare. CONCLUSION: The case study revealed a lack of systemic grounding of HR services as interdisciplinary health-social services. The aftermath of the financial crisis in 2008 fully revealed the limitations of the funding system established ad hoc in the 1990s, which remains present until today, together with all its weak points. The entire situation is responsible for the dangerous erosion of the interpretation of the concept of harm reduction, which is supported by various stereotypes and false, or ideological, interpretations of the concept. BioMed Central 2020-10-22 /pmc/articles/PMC7579931/ /pubmed/33092597 http://dx.doi.org/10.1186/s12954-020-00428-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Miovský, Michal
Miklíková, Silvia
Mravčík, Viktor
Grund, Jean-Paul
Černíková, Tereza
Understanding the crisis in harm reduction funding in Central and Eastern Europe
title Understanding the crisis in harm reduction funding in Central and Eastern Europe
title_full Understanding the crisis in harm reduction funding in Central and Eastern Europe
title_fullStr Understanding the crisis in harm reduction funding in Central and Eastern Europe
title_full_unstemmed Understanding the crisis in harm reduction funding in Central and Eastern Europe
title_short Understanding the crisis in harm reduction funding in Central and Eastern Europe
title_sort understanding the crisis in harm reduction funding in central and eastern europe
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579931/
https://www.ncbi.nlm.nih.gov/pubmed/33092597
http://dx.doi.org/10.1186/s12954-020-00428-6
work_keys_str_mv AT miovskymichal understandingthecrisisinharmreductionfundingincentralandeasterneurope
AT miklikovasilvia understandingthecrisisinharmreductionfundingincentralandeasterneurope
AT mravcikviktor understandingthecrisisinharmreductionfundingincentralandeasterneurope
AT grundjeanpaul understandingthecrisisinharmreductionfundingincentralandeasterneurope
AT cernikovatereza understandingthecrisisinharmreductionfundingincentralandeasterneurope